Epstein Barr-Virus in multiple sclerosis: Where are we? Where should we go?


Bilde
Logo of the ECTRIMS 2025 conference.
Photo: ECTRIMS

41st ECTRIMS Congress (Barcelona, Spain) presents an Educational Session on EBV and MS with presentations by members of the EBV-MS consortium.

We are excited that this year’s ECTRIMS congress, taking place in Barcelona from the September 24-26, will feature an educational session on the “Epstein Barr-Virus in Multiple Sclerosis: Where are we? Where should we go?” chaired by Dr. Jan Lünemann from Münster and Dr. Marianna Cortese from Boston. This educational session will take place September 24 from 8:30 to 9:30 am and will be a joint initiative between the BEHIND-MS project and the EBV-MS project, two ambitious EU-funded consortia focused on elucidating the role of EBV infection in the onset and progression of MS.

Presentations in Educational Session 1: 

  • Introduction by the chairs
  • EBV in MS: guilty by association? Insights from epidemiological studie (Marianna Cortese)
  • Immune control of EBV infection: what is different in people with MS? (Jan  Lünemann)
  • Targeting EBV infection for treatment and prevention of MS: fact or fiction? (Øivind Torkildsen)
  • Discussion

For more information, please visit the ECTRIMS web page (external link).